TARS - Tarsus Pharmaceuticals, Inc.

QQQ $ 622.38 $ 4.94 (0.8 %)

DIA $ 473.04 $ 2.23 (0.47 %)

SPY $ 677.28 $ 2.47 (0.37 %)

TLT $ 89.01 $ -0.57 (-0.64 %)

GLD $ 365.20 $ 0.10 (0.03 %)

Previous Close

$ 68.2

Open

$ 68.50

Bid

$ 68.20 x 1

Ask

$ 70.00 x 30

Day's Range

$ 67.49 - $ 71.95

52 Week Range

$ 38.51 - $ 76.81

Volume

958,284

Average Volume

Market Cap

2.9B

Beta (5Y Monthly)

$ 0.72

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-04-2025	09-30-2025	10-Q
2	08-06-2025	06-30-2025	10-Q
3	05-01-2025	03-31-2025	10-Q
4	02-25-2025	12-31-2024	10-K
5	11-13-2024	09-30-2024	10-Q
6	08-08-2024	06-30-2024	10-Q
7	05-08-2024	03-31-2024	10-Q
8	02-27-2024	12-31-2023	10-K
9	11-09-2023	09-30-2023	10-Q
10	08-10-2023	06-30-2023	10-Q
11	05-09-2023	03-31-2023	10-Q
12	03-17-2023	12-31-2022	10-K
13	11-09-2022	09-30-2022	10-Q
14	08-11-2022	06-30-2022	10-Q
15	05-11-2022	03-31-2022	10-Q
16	03-14-2022	12-31-2021	10-K
17	11-10-2021	09-30-2021	10-Q
18	08-04-2021	06-30-2021	10-Q
19	05-11-2021	03-31-2021	10-Q
20	03-31-2021	12-31-2020	10-K
21	11-25-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Guggenheim Maintains Buy on Tarsus Pharmac...
11/05/2025 15:04:29

Guggenheim analyst Eddie Hickman maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and raises the price target from ...

Tarsus Pharmaceuticals Q3 EPS $(0.30) Beat...
11/04/2025 21:06:03

Tarsus Pharmaceuticals (NASDAQ:TARS) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate o...

Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

HC Wainwright & Co. Maintains Buy on Tarsu...
10/20/2025 10:40:10

HC Wainwright & Co. analyst Matthew Caufield maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and raises the pr...

top-2-health-care-stocks-that-may-fall-off-a-cliff-in-august

Top 2 Health Care Stocks That May Fall Off...
08/20/2025 12:46:03

Tarsus Pharmaceuticals Q2 EPS $(0.48) Miss...
08/06/2025 20:06:29

Tarsus Pharmaceuticals (NASDAQ:TARS) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate...

Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

Tarsus Pharmaceuticals Stock: A Deep Dive ...
05/27/2025 13:01:06

HC Wainwright & Co. Assumes Tarsus Pharmac...
05/27/2025 10:34:36

HC Wainwright & Co. analyst Matthew Caufield assumes Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy rating and announce...

6 Analysts Assess Tarsus Pharmaceuticals: ...
05/05/2025 22:00:35

elanco-animal-health-sells-xdemvy-royalties-to-blackstone-in-295-million-deal

Elanco Animal Health Sells Xdemvy Royaltie...
05/05/2025 20:40:36

Elanco sells U.S. Xdemvy royalties to Blackstone for $295 million, aiming to lower debt and cut interest costs while retaining ...

Goldman Sachs Maintains Neutral on Tarsus ...
05/05/2025 15:07:38

Goldman Sachs analyst Andrea Tan maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Neutral and raises the price target f...

Elanco Monetizes XDEMVY Royalties in $295M...
05/05/2025 10:29:02

Elanco Animal Health Incorporated (NYSE:ELAN) today announced the sale of certain future tiered royalties and commercial milest...

Guggenheim Maintains Buy on Tarsus Pharmac...
05/02/2025 16:15:46

Guggenheim analyst Eddie Hickman maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and raises the price target from ...

Tarsus Pharmaceuticals Q1 EPS $(0.64) Beat...
05/01/2025 20:10:55

Earnings Scheduled For May 1, 2025
05/01/2025 08:32:37

An Overview of Tarsus Pharmaceuticals's Ea...
04/30/2025 20:01:42

Tarsus To Present Several Scientific Abstr...
04/22/2025 12:33:38

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) will present four distinct data sets highlighting the global prevalence and real-wor...

Reported Earlier, Tarsus Pharmaceuticals P...
03/13/2025 05:29:56

Tarsus Announces Proposed $100M Public Off...
03/12/2025 20:15:16